SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $321,000 | +9.6% | 11,000 | 0.0% | 0.05% | +9.5% |
| Q3 2021 | $293,000 | -13.6% | 11,000 | 0.0% | 0.04% | -6.7% |
| Q2 2021 | $339,000 | +17.7% | 11,000 | 0.0% | 0.04% | +9.8% |
| Q1 2021 | $288,000 | -37.4% | 11,000 | -39.9% | 0.04% | -36.9% |
| Q4 2020 | $460,000 | +20.7% | 18,300 | 0.0% | 0.06% | 0.0% |
| Q3 2020 | $381,000 | -12.4% | 18,300 | 0.0% | 0.06% | -7.1% |
| Q2 2020 | $435,000 | +15.1% | 18,300 | -12.9% | 0.07% | +14.8% |
| Q1 2020 | $378,000 | -24.1% | 21,000 | 0.0% | 0.06% | +22.0% |
| Q4 2019 | $498,000 | +105.8% | 21,000 | +138.6% | 0.05% | +100.0% |
| Q3 2019 | $242,000 | – | 8,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |